Lv51
1470 积分 2023-09-06 加入
Regimen-stratified Bayesian model-based meta-analysis of targeted biologics in generalised myasthenia gravis: efficacy comparison, mechanism-level class contrast, and endpoint sensitivity with model-informed trial design
6小时前
已完结
Next-generation immune cell engagers for B cell depletion in autoimmune diseases
5天前
已完结
A bispecific CD3×CD19 antibody for systemic lupus erythematosus: a phase 1 trial
1个月前
已完结
Single-cell profiling of immune reset in patients with refractory generalized myasthenia gravis receiving autologous CD19/BCMA CAR-T cell therapy
5个月前
已完结
Global epidemiology and burden of interstitial lung disease
5个月前
已完结
Teclistamab in Relapsed or Refractory Multiple Myeloma
5个月前
已完结
Standardization of Myasthenia Gravis Outcome Measures in Clinical Practice. A Report of the MGFA Task Force
5个月前
已完结
Non-ICANS neurological complications after CAR T-cell therapies: recommendations from the EBMT Practice Harmonisation and Guidelines Committee
5个月前
已完结
Bispecific T cell engager therapy for refractory rheumatoid arthritis
5个月前
已完结
Interstitial lung diseases
6个月前
已完结
皖公网安备34019202002308
